CompoAtlas

BIO 88

Natural health product licensed in Canada

Licence holder
Bio Lonreco Inc.
NPN or DIN-HM
80033856
Status
Active licence
Licence date
23 July 2012
Revision date
23 February 2026
Form
Liquide
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Mononucléose

Source : Salive de patients atteints de la fièvre glandulaire (mononucléose) causée par le virus Epstein-Barr

200 DNot calculated
Diptherinum

Source : Membrane infectée de diphtérie

60 DNot calculated
Influenzinum

Source : Virus de la grippe A et B inactivé provenant de l'embryon de poulet, individuellement ou en combinaison

200 DNot calculated
Influenzinum

Source : Virus de la grippe A et B inactivé provenant de l'embryon de poulet, individuellement ou en combinaison

60 DNot calculated
Herpes zoster

Source : Sécrétions provenant des vésicules de la varicelle à divers endroits et à divers stades

30 DNot calculated
Morbillinum

Source : Exudats bucco-pharyngés provenant des humains infectés avec la rougeole

30 DNot calculated
Herpes zoster

Source : Sécrétions provenant des vésicules de la varicelle à divers endroits et à divers stades

200 DNot calculated
Morbillinum

Source : Exudats bucco-pharyngés provenant des humains infectés avec la rougeole

60 DNot calculated
Diptherinum

Source : Membrane infectée de diphtérie

30 DNot calculated
Poliomyélite

Source : Liquide céphalorachidien obtenu par ponction lombaire sur des patients atteints de poliomyélite

200 DNot calculated
Coxsackie

Source : Virus Coxsackie inactivé des sous-groupes A9 et B4

200 DNot calculated
Epstein Barr

Source : Virus Epstein Barr

30 DNot calculated
Herpes simplex

Source : Sécrétions de Herpes simplex provenant des vésicules

30 DNot calculated
Morbillinum

Source : Exudats bucco-pharyngés provenant des humains infectés avec la rougeole

200 DNot calculated
Diptherinum

Source : Membrane infectée de diphtérie

200 DNot calculated
Herpes zoster

Source : Sécrétions provenant des vésicules de la varicelle à divers endroits et à divers stades

60 DNot calculated

Non-medicinal ingredients

Éthanol, Eau purifiée

PopulationAgeQuantity per servingFrequency
Adultes et enfantsminimum: 12 yearsminimum: 5 Goutte(s) ; maximum: 10 Goutte(s)3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Nosodes and homeopathic remedy to be used on the advice of a health care practitioner.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80033856

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line